Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Therapy

Nonhormonal treatment of hot flashes—a viable alternative?

Nature Reviews Endocrinology volume 6, pages 66–67 (2010)Cite this article

Subjects

A new study published in the Journal of Clinical Oncology has ascertained the efficacy of selective serotonin-reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors and gabapentin to decrease menopausal hot flashes. Are these nonhormonal treatment options a viable alternative to hormone replacement therapy?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Loprinzi, C. L. et al. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J. Clin. Oncol. 16, 2377–2381 (1998).

    Article  CAS  PubMed  Google Scholar 

  2. Loprinzi, C. L. et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356, 2059–2063 (2000).

    Article  CAS  PubMed  Google Scholar 

  3. Guttuso, T. J. Jr. Gabapentin's effects on hot flashes and hypothermia. Neurology 54, 2161–2163 (2000).

    Article  PubMed  Google Scholar 

  4. Loprinzi, C. L. et al. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J. Clin. Oncol. 27, 2831–2837 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Loprinzi, C. L., Diekmann, B., Novotny, P. J., Stearns, V. & Sloan, J. A. Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause 16, 883–887 (2009).

    Article  PubMed  Google Scholar 

  6. Genazzani, A. B. et al. Endocrinology of menopausal transition and its brain implications. CNS Spectr. 10, 449–457 (2005).

    Article  PubMed  Google Scholar 

  7. Stearns, V. et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J. Natl Cancer Inst. 95, 1758–1764 (2003).

    Article  CAS  PubMed  Google Scholar 

  8. Goetz, M. P. et al. Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes. J. Clin. Oncol. 23, 9312–9318 (2005).

    Article  CAS  PubMed  Google Scholar 

  9. Sturdee, D. W. The menopausal hot flash—anything new? Maturitas 60, 42–49 (2008).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, New York University School of Medicine, 251 East 33rd Street, New York, 10016, NY, USA

    Lila E. Nachtigall

Authors
  1. Lila E. Nachtigall
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares associations with the following companies: Novo Nordisk (consultant, grant/research support), Procter & Gamble (grant/research support), Securelabs (consultant, grant/research support), Upsher-Smith (speaker), Wyeth (speaker).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nachtigall, L. Nonhormonal treatment of hot flashes—a viable alternative?. Nat Rev Endocrinol 6, 66–67 (2010). https://doi.org/10.1038/nrendo.2009.269

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrendo.2009.269

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing